Delivery Order SPE2DX22D0010-SPE2D826FAS12
- Not listed
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Nucynta ER (extended-release tapentadol) 150mg tablets, a Schedule II opioid analgesic used for pain management. The contract, valued at $11,156.46, represents a firm fixed-price delivery order with an ultimate completion date of August 13, 2025, and was competitively awarded without set-aside provisions. The performance location is...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Nucynta ER (tapentadol extended-release) 100mg tablets, valued at $6,005.43. This firm fixed-price delivery order, which represents a child contract under a larger vehicle, is scheduled for completion by August 5, 2025, and will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. The award was made through open...
- The Defense Logistics Agency Medical Supply Chain awarded a $2,917.26 firm fixed-price delivery order to AmerisourceBergen Drug Corp on October 6, 2025, for the supply of Nucynta ER (extended-release tapentadol) 50mg tablets. This is a non-set-aside competitive award with an ultimate completion date of October 7, 2025, to be performed at the contractor's Conshohocken, Pennsylvania facility. The delivery order represents a child contract under AmerisourceBergen's larger pharmaceutical prime...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $10,288.63 on July 25, 2025, for the supply of Nucynta Tabs 50mg under a firm fixed price contract. This non-set-aside award is funded by the Defense Logistics Agency's Medical Supply Chain and is scheduled for completion by July 28, 2025. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on October 7, 2025, for the supply of Nucynta Tabs 50mg, a pain management pharmaceutical. This firm fixed-price delivery order, valued at $4,442.48, is scheduled for completion by October 8, 2025, and will be fulfilled from the contractor's facility in Conshohocken, Pennsylvania. The award was competitively awarded with no set-aside designation, reflecting AmerisourceBergen's proven...
- The Defense Logistics Agency awarded a $2,862.27 firm fixed price delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Nucynta (tapentadol) 100 mg tablets in a 100-count package. This competitively awarded, non-set-aside contract will be performed at the vendor's corporate headquarters in Conshohocken, Pennsylvania, with an ultimate completion date of August 21, 2025. The delivery order represents a child contract action under AmerisourceBergen Drug Corp's larger...
- The Defense Logistics Agency awarded a delivery order valued at $2,848.19 to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Nucynta (tapentadol) 50 mg tablets in a quantity of 100 units. This is a firm fixed-price delivery order with no set-aside designation, representing a competitive award under the company's larger indefinite delivery contract with DLA Troop Support Medical. The product will be performed at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Nucynta (tapentadol) 50 mg tablets in quantities of 100 units. This is a firm fixed-price delivery order with a ceiling value of $1,225.04 and an ultimate completion date of August 6, 2025. The award represents a non-competitive action under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (contract SPE2DX), valued at $999,999,999.00...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on October 21, 2025, for the supply of Nucynta Tabs 50mg, a pain management pharmaceutical. This firm fixed-price delivery order, valued at $7,938.87, represents a non-competitive set-aside contract and is scheduled for completion by October 22, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal medical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 21, 2025, for the supply of Nucynta 50 mg tablets (100-count package) with a ceiling value of $1,225.04. This firm fixed-price delivery order, which is expected to be completed by August 22, 2025, represents a non-competitive, non-set-aside award and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract falls under AmerisourceBergen's larger...
- SPE2DX22D0010Indefinite Delivery Contract
- SPE2DX22D0010-SPE2D826FAS12Delivery Order
The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on October 29, 2025, for the supply of Nucynta Tabs 50mg (tapentadol), a Schedule II opioid pain medication. This firm fixed-price delivery order, valued at $13,592.97, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) designated SPE2DX with DLA Troop Support Medical, which carries a ceiling value of $999,999,999.00 through December 2026. The award was made through open competition with no set-aside designation, reflecting AmerisourceBergen's competitive capability to meet federal pharmaceutical procurement requirements. Performance will be completed by October 30, 2025, at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp serves as a critical pharmaceutical distributor for federal medical procurement, supplying a comprehensive portfolio of brand-name and generic medications, vaccines, and medical devices to support military and veteran healthcare systems. The company's extensive federal contracting history demonstrates its ability to fulfill diverse medical supply needs ranging from specialty medications to routine pharmaceuticals across multiple therapeutic domains. This delivery order for Nucynta Tabs supports the Defense Health Agency and broader Defense Department healthcare operations through AmerisourceBergen's established prime vendor relationship, enabling efficient procurement of controlled pharmaceutical substances for military medical facilities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $13.6k | 10/29/25 |